
Sunil Jeram Advani MD
Assistant Professor, Radiation Medicine and Applied Sciences, UCSD School of Medicine
Join to view full profile
3855 Health Sciences Dr# UcsdLa Jolla, CA 92093
Phone+1 858-822-4364
Fax+1 858-822-7400
Dr. Advani is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2005 - 2009
Oregon Health Science University HospitalInternship, Transitional Year, 2004 - 2005
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1999
Certifications & Licensure
OR State Medical License 2004 - Present
CA State Medical License 2009 - 2027
IL State Medical License 2008 - 2009
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- NIH/NCI R37 MERIT Award NIH/NCI
- CMS Meaningful Use Stage 1 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2015, 2017
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Radiation Oncology), Varian Medical Systems, 2015, 2017
Publications & Presentations
PubMed
- Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses.Kanika Dhawan, Michael M Allevato, Jacqueline Lesperance, Maria F Camargo, Marcus M Cheng
Cancer Letters. 2026-10-01 - Interactions of Antibody Drug Conjugate Anti-Tubulin and Topoisomerase I Inhibitor Payloads with Radiotherapy to Potentiate Immunotherapy.Jacqueline Lesperance, Bryan S Yung, Michael M Allevato, Marcus M Cheng, Maria F Camargo
Advanced Science. 2026-06-01 - Orthogonally targeted tumor radiosensitization using cell penetrating peptide-ATM inhibitor conjugates to stimulate anti-tumor immune responses.Kanika Dhawan, Michael M Allevato, Jacqueline Lesperance, Maria F Camargo, Marcus M Cheng
Biorxiv. 2026-01-12
Press Mentions
LJI Scientists Receive Curebound Funding to Advance Cancer ResearchMarch 17th, 2025
Grant Support
- Spatially precise radio-chemo-immunotherapy using antibody conjugatesUNIVERSITY OF CALIFORNIA, SAN DIEGO2022–2027
- Elucidation and therapeutic exploitation of PAK mediated radioresistanceUNIVERSITY OF CALIFORNIA, SAN DIEGO2017–2025
Research History
- Post-Doctoral Research FellowMolecular Virology1999 - 2004
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









